LOS ANGELES, CA--(Marketwired - Aug 17, 2016) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, ...
As VBIO's studies continue, the company is encouraged by both pre-clinical and case study data which suggest that Vitality Biopharma is well on track to create meaningful THC prodrug treatments for ...
Beginning in 2014, marijuana stocks were in vogue. Investors were scrambling the markets to find almost any stock that promoted themselves as an emerging player in the cannabis industry. The drawback ...
NEW YORK, NY / ACCESSWIRE / September 27, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 ...
Vitality Biopharma recently announced it would begin trading under the stock ticker symbol VBIO. Here’s what you need to know. 1. The company is dedicated to the “development of cannabinoid prodrug ...
The top marijuana penny stocks to watch in November 2017 include last month's biggest gainers.
As VBIO's studies continue, the company is encouraged by both pre-clinical and case study data which suggest that Vitality Biopharma is well on track to create meaningful THC prodrug treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results